Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

China flag China · Delayed Price · Currency is CNY
7.75
+0.09 (1.17%)
Mar 10, 2026, 3:00 PM CST
-28.96%
Market Cap 7.19B
Revenue (ttm) 1.59B
Net Income (ttm) -332.62M
Shares Out 939.26M
EPS (ttm) -0.35
PE Ratio n/a
Forward PE n/a
Dividend 0.15 (1.96%)
Ex-Dividend Date n/a
Volume 8,784,801
Average Volume 14,156,368
Open 7.66
Previous Close 7.66
Day's Range 7.66 - 7.84
52-Week Range 7.40 - 13.48
Beta 0.23
RSI 32.71
Earnings Date Apr 23, 2026

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China. [Read more]

Sector Healthcare
Founded 1996
Employees 2,349
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603567
Full Company Profile

Financial Performance

In 2024, SHA:603567's revenue was 2.70 billion, a decrease of -13.84% compared to the previous year's 3.14 billion. Earnings were 438.22 million, a decrease of -7.30%.

Financial Statements

News

There is no news available yet.